Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference.


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
10 2022
Historique:
received: 15 05 2022
accepted: 24 05 2022
pubmed: 15 8 2022
medline: 21 9 2022
entrez: 14 8 2022
Statut: ppublish

Résumé

Endoscopy plays a critical role in caring for and evaluating the patient with eosinophilic esophagitis (EoE). Endoscopy is essential for diagnosis, assessment of response to therapy, treatment of esophageal strictures, and ongoing monitoring of patients in histologic remission. To date, less-invasive testing for identifying or grading EoE severity has not been established, whereas diagnostic endoscopy as integral to both remains the criterion standard. Therapeutic endoscopy in patients with adverse events of EoE may also be required. In particular, dilation may be essential to treat and attenuate progression of the disease in select patients to minimize further fibrosis and stricture formation. Using a modified Delphi consensus process, a group of 20 expert clinicians and investigators in EoE were assembled to provide guidance for the use of endoscopy in EoE. Through an iterative process, the group achieved consensus on 20 statements yielding comprehensive advice on tissue-sampling standards, gross assessment of disease activity, use and performance of endoscopic dilation, and monitoring of disease, despite an absence of high-quality evidence. Key areas of controversy were identified when discussions yielded an inability to reach agreement on the merit of a statement. We expect that with ongoing research, higher-quality evidence will be obtained to enable creation of a guideline for these issues. We further anticipate that forthcoming expert-generated and agreed-on statements will provide valuable practice advice on the role and use of endoscopy in patients with EoE.

Identifiants

pubmed: 35965102
pii: S0016-5107(22)01725-4
doi: 10.1016/j.gie.2022.05.013
pii:
doi:

Types de publication

Practice Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

576-592.e1

Informations de copyright

Copyright © 2022 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Seema S Aceves (SS)

Division of Allergy, Immunology, Departments of Pediatrics and Medicine, University of California San Diego and Rady Children's Hospital, San Diego, California, USA.

Jeffrey A Alexander (JA)

Departments of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Todd H Baron (TH)

Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Arjan J Bredenoord (AJ)

Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.

Lukejohn Day (L)

Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Evan S Dellon (ES)

Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Gary W Falk (GW)

University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.

Glenn T Furuta (GT)

Department of Pediatrics, Gastrointestinal Eosinophilic Diseases Program and Mucosal Inflammation Program, University of Colorado School of Medicine, Digestive Health Institute, Children's Hospital Colorado, Aurora, Colorado, USA.

Nirmala Gonsalves (N)

Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Ikuo Hirano (I)

Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Vani J A Konda (VJA)

Baylor University Medical Center, Dallas, Texas, USA.

Alfredo J Lucendo (AJ)

Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain.

Fouad Moawad (F)

Scripps Health Uniformed Services, La Jolla, California, USA.

Kathryn A Peterson (KA)

Division of Gastroenterology, Hepatology, and Nutrition, University of Utah Health, Salt Lake City, Utah, USA.

Philip E Putnam (PE)

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Joel Richter (J)

University of South Florida Health, Tampa, Florida, USA.

Alain M Schoepfer (AM)

Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausannel, Lausanne, Switzerland.

Alex Straumann (A)

Facharzt FMH fur Gastroenterologie u Innere Medizin, Olten, Switzerland.

Deborah L McBride (DL)

Consultant, Chicago, Illinois, USA.

Prateek Sharma (P)

Division of Gastroenterology, Hepatology, and Motility, University of Kansas Medical Center, Kansas City, Kansas, USA.

David A Katzka (DA)

Division of Gastroenterology, Columbia University Medical Center, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH